Literature DB >> 19057511

PTEN regulation by Akt-EGR1-ARF-PTEN axis.

Jianxiu Yu1, Sharon S Zhang, Kan Saito, Scott Williams, Yutaka Arimura, Yuliang Ma, Yuehai Ke, Veronique Baron, Dan Mercola, Gen-Sheng Feng, Eileen Adamson, Tomas Mustelin.   

Abstract

The PTEN tumour suppressor gene is induced by the early growth response 1 (EGR1) transcription factor, which also transactivates p53, p73, and p300/CBP as well as other proapoptotic and anti-cancer genes. Here, we describe a novel Akt-EGR1-alternate reading frame (ARF)-PTEN axis, in which PTEN activation in vivo requires p14ARF-mediated sumoylation of EGR1. This modification is dependent on the phosphorylation of EGR1 at S350 and T309 by Akt, which promotes interaction of EGR1 with ARF at K272 in its repressor domain by the ARF/Ubc9/SUMO system. EGR1 sumoylation is decreased by ARF reduction, and no EGR1 sumoylation is detected in ARF(-/-) mice, which also exhibit reduced amounts of PTEN. Our model predicts that perturbation of any of the clinically important tumour suppressors, PTEN, EGR1, and ARF, will cause some degree of dysfunction of the others. These results also explain the known negative feedback regulation by PTEN on its own synthesis through PI3 kinase inhibition.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19057511      PMCID: PMC2633077          DOI: 10.1038/emboj.2008.238

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  40 in total

1.  Escape of p53 protein from E6-mediated degradation in HeLa cells after cisplatin therapy.

Authors:  Józefa Wesierska-Gadek; Daniela Schloffer; Vladimir Kotala; Marcel Horky
Journal:  Int J Cancer       Date:  2002-09-10       Impact factor: 7.396

2.  Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14(ARF) tumor suppressor.

Authors:  G P Dimri; K Itahana; M Acosta; J Campisi
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

3.  Human ARF protein interacts with topoisomerase I and stimulates its activity.

Authors:  L Karayan; J F Riou; P Séité; J Migeon; A Cantereau; C J Larsen
Journal:  Oncogene       Date:  2001-02-15       Impact factor: 9.867

4.  The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling.

Authors:  T Virolle; E D Adamson; V Baron; D Birle; D Mercola; T Mustelin; I de Belle
Journal:  Nat Cell Biol       Date:  2001-12       Impact factor: 28.824

5.  P14ARF promotes accumulation of SUMO-1 conjugated (H)Mdm2.

Authors:  Dimitris P Xirodimas; June Chisholm; Joana M S Desterro; David P Lane; Ronald T Hay
Journal:  FEBS Lett       Date:  2002-09-25       Impact factor: 4.124

6.  Regulation of PTEN transcription by p53.

Authors:  V Stambolic; D MacPherson; D Sas; Y Lin; B Snow; Y Jang; S Benchimol; T W Mak
Journal:  Mol Cell       Date:  2001-08       Impact factor: 17.970

7.  MDM2-ARF complex regulates p53 sumoylation.

Authors:  Lihong Chen; Jiandong Chen
Journal:  Oncogene       Date:  2003-08-14       Impact factor: 9.867

8.  Negative feedback regulation of the tumor suppressor PTEN by phosphoinositide-induced serine phosphorylation.

Authors:  Diana Birle; Nunzio Bottini; Scott Williams; Huong Huynh; Ian deBelle; Eileen Adamson; Tomas Mustelin
Journal:  J Immunol       Date:  2002-07-01       Impact factor: 5.422

9.  The alternative reading frame tumor suppressor antagonizes hypoxia-induced cancer cell migration via interaction with the COOH-terminal binding protein corepressor.

Authors:  Seema Paliwal; Ramesh C Kovi; Bharath Nath; Ya-Wen Chen; Brian C Lewis; Steven R Grossman
Journal:  Cancer Res       Date:  2007-10-01       Impact factor: 12.701

Review 10.  The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network.

Authors:  Lindsey D Mayo; David B Donner
Journal:  Trends Biochem Sci       Date:  2002-09       Impact factor: 13.807

View more
  66 in total

1.  ΔNp63α regulates keratinocyte proliferation by controlling PTEN expression and localization.

Authors:  M K Leonard; R Kommagani; V Payal; L D Mayo; H N Shamma; M P Kadakia
Journal:  Cell Death Differ       Date:  2011-06-03       Impact factor: 15.828

2.  BubR1 is modified by sumoylation during mitotic progression.

Authors:  Feikun Yang; Liyan Hu; Cheng Chen; Jianxiu Yu; Christopher B O'Connell; Alexey Khodjakov; Michele Pagano; Wei Dai
Journal:  J Biol Chem       Date:  2011-12-13       Impact factor: 5.157

3.  Tumor suppression by the EGR1, DMP1, ARF, p53, and PTEN Network.

Authors:  Kazushi Inoue; Elizabeth A Fry
Journal:  Cancer Invest       Date:  2018-11-05       Impact factor: 2.176

4.  A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma.

Authors:  Corine Bertolotto; Fabienne Lesueur; Sandy Giuliano; Thomas Strub; Mahaut de Lichy; Karine Bille; Philippe Dessen; Benoit d'Hayer; Hamida Mohamdi; Audrey Remenieras; Eve Maubec; Arnaud de la Fouchardière; Vincent Molinié; Pierre Vabres; Stéphane Dalle; Nicolas Poulalhon; Tanguy Martin-Denavit; Luc Thomas; Pascale Andry-Benzaquen; Nicolas Dupin; Françoise Boitier; Annick Rossi; Jean-Luc Perrot; Bruno Labeille; Caroline Robert; Bernard Escudier; Olivier Caron; Laurence Brugières; Simon Saule; Betty Gardie; Sophie Gad; Stéphane Richard; Jérôme Couturier; Bin Tean Teh; Paola Ghiorzo; Lorenza Pastorino; Susana Puig; Celia Badenas; Hakan Olsson; Christian Ingvar; Etienne Rouleau; Rosette Lidereau; Philippe Bahadoran; Philippe Vielh; Eve Corda; Hélène Blanché; Diana Zelenika; Pilar Galan; François Aubin; Bertrand Bachollet; Céline Becuwe; Pascaline Berthet; Yves Jean Bignon; Valérie Bonadona; Jean-Louis Bonafe; Marie-Noëlle Bonnet-Dupeyron; Fréderic Cambazard; Jacqueline Chevrant-Breton; Isabelle Coupier; Sophie Dalac; Liliane Demange; Michel d'Incan; Catherine Dugast; Laurence Faivre; Lynda Vincent-Fétita; Marion Gauthier-Villars; Brigitte Gilbert; Florent Grange; Jean-Jacques Grob; Philippe Humbert; Nicolas Janin; Pascal Joly; Delphine Kerob; Christine Lasset; Dominique Leroux; Julien Levang; Jean-Marc Limacher; Cristina Livideanu; Michel Longy; Alain Lortholary; Dominique Stoppa-Lyonnet; Sandrine Mansard; Ludovic Mansuy; Karine Marrou; Christine Matéus; Christine Maugard; Nicolas Meyer; Catherine Nogues; Pierre Souteyrand; Laurence Venat-Bouvet; Hélène Zattara; Valérie Chaudru; Gilbert M Lenoir; Mark Lathrop; Irwin Davidson; Marie-Françoise Avril; Florence Demenais; Robert Ballotti; Brigitte Bressac-de Paillerets
Journal:  Nature       Date:  2011-10-19       Impact factor: 49.962

5.  Microsomal prostaglandin E synthase-1 inhibits PTEN and promotes experimental cholangiocarcinogenesis and tumor progression.

Authors:  Dongdong Lu; Chang Han; Tong Wu
Journal:  Gastroenterology       Date:  2011-02-24       Impact factor: 22.682

6.  The AKT signaling pathway sustains the osteogenic differentiation in human dental follicle cells.

Authors:  S Viale-Bouroncle; C Klingelhöffer; T Ettl; C Morsczeck
Journal:  Mol Cell Biochem       Date:  2015-05-16       Impact factor: 3.396

7.  Expression of early growth response gene-1 in precancerous lesions of gastric cancer.

Authors:  Seon-Young Park; Ji-Young Kim; Su-Mi Lee; Jin Ook Chung; Kyung-Hwa Lee; Chung-Hwan Jun; Chang-Hwan Park; Hyun-Soo Kim; Sung-Kyu Choi; Jong-Sun Rew; Young-Do Jung; Yong Han Lee
Journal:  Oncol Lett       Date:  2016-08-05       Impact factor: 2.967

8.  A novel system for studying mechanical strain waveform-dependent responses in vascular smooth muscle cells.

Authors:  Jason Lee; Mitchell Wong; Quentin Smith; Aaron B Baker
Journal:  Lab Chip       Date:  2013-12-07       Impact factor: 6.799

Review 9.  Regulation and modulation of PTEN activity.

Authors:  Elahe Naderali; Amir Afshin Khaki; Jafar Soleymani Rad; Alireza Ali-Hemmati; Mohammad Rahmati; Hojjatollah Nozad Charoudeh
Journal:  Mol Biol Rep       Date:  2018-08-25       Impact factor: 2.316

10.  ARF represses androgen receptor transactivation in prostate cancer.

Authors:  Wenfu Lu; Yingqiu Xie; Yufang Ma; Robert J Matusik; Zhenbang Chen
Journal:  Mol Endocrinol       Date:  2013-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.